BioAgeGap

1. BioAgeGap is associated with diabetes in humans.

   “The top BioAgeGap quartile also had a significantly higher prevalence of clinical CKM indicators, including hypertension, kidney disease, and diabetes (UK Biobank) or suboptimally controlled diabetes (EyePACS).”

   Humanstop BioAgeGap quartile

   Retinal BioAge is associated with indicators of cardiovascular-kidney-metabolic syndrome in UK and US populations

   Scientific reports·25 Feb 2026

More on Diabetes

1. BioAgeGap is associated with kidney disease in humans.

   “The top BioAgeGap quartile also had a significantly higher prevalence of clinical CKM indicators, including hypertension, kidney disease, and diabetes (UK Biobank) or suboptimally controlled diabetes (EyePACS).”

   Humanstop BioAgeGap quartile

   Retinal BioAge is associated with indicators of cardiovascular-kidney-metabolic syndrome in UK and US populations

   Scientific reports·25 Feb 2026

More on Kidney disease

1. BioAgeGap is associated with hypertension in humans.

   “The top BioAgeGap quartile also had a significantly higher prevalence of clinical CKM indicators, including hypertension, kidney disease, and diabetes (UK Biobank) or suboptimally controlled diabetes (EyePACS).”

   Humanstop BioAgeGap quartile

   Retinal BioAge is associated with indicators of cardiovascular-kidney-metabolic syndrome in UK and US populations

   Scientific reports·25 Feb 2026

More on Hypertension

1. BioAgeGap is associated with cardiovascular-kidney-metabolic syndrome in humans.

   “In both datasets, CKM biomarker profiles were significantly worse for the top vs. bottom quartiles of BioAgeGap (retinal BioAge-chronological age), including measures of blood pressure, kidney function, adiposity, and glycemia.”

   Humanstop vs. bottom quartiles of BioAgeGap

   Retinal BioAge is associated with indicators of cardiovascular-kidney-metabolic syndrome in UK and US populations

   Scientific reports·25 Feb 2026

More on Cardiovascular-kidney-metabolic syndrome